CRD-4730

N/A

Report date: 2026/02/28 20:00:37

Base Information

Drug NameCRD-4730
Drug Alias NameCRD-4730
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium/Calmodulin dependent protein kinase II inhibitors
TargetsCalcium/Calmodulin dependent protein kinase II
Therapy Area/IndicationsTachycardia, VentricularHeart DiseasesHeart Defects, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCardurion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCardurion Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsTachycardia, Ventricular
Inactive IndicationsHeart DiseasesHeart Defects, Congenital

Other Information

ATC CodeN/A
Related LinksN/A